450 related articles for article (PubMed ID: 19846301)
1. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
Carta F; Maresca A; Covarrubias AS; Mowbray SL; Jones TA; Supuran CT
Bioorg Med Chem Lett; 2009 Dec; 19(23):6649-54. PubMed ID: 19846301
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT
J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules.
Singh S; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):449-55. PubMed ID: 23808803
[TBL] [Abstract][Full Text] [Related]
6. The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets.
Nishimori I; Minakuchi T; Maresca A; Carta F; Scozzafava A; Supuran CT
Curr Pharm Des; 2010; 16(29):3300-9. PubMed ID: 20819064
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.
Maresca A; Vullo D; Scozzafava A; Manole G; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):392-6. PubMed ID: 22299588
[TBL] [Abstract][Full Text] [Related]
9. Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis.
Maresca A; Scozzafava A; Vullo D; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):384-7. PubMed ID: 22214209
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
Isik S; Kockar F; Aydin M; Arslan O; Guler OO; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2009 Feb; 17(3):1158-63. PubMed ID: 19124253
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
[TBL] [Abstract][Full Text] [Related]
13. Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
Nishimori I; Vullo D; Minakuchi T; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem; 2014 Jun; 22(11):2939-46. PubMed ID: 24792813
[TBL] [Abstract][Full Text] [Related]
14. Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis.
Maresca A; Carta F; Vullo D; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):407-11. PubMed ID: 22145736
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
[TBL] [Abstract][Full Text] [Related]
16. A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
Joseph P; Ouahrani-Bettache S; Montero JL; Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Winum JY; Köhler S; Supuran CT
Bioorg Med Chem; 2011 Feb; 19(3):1172-8. PubMed ID: 21251841
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
Bertucci A; Innocenti A; Zoccola D; Scozzafava A; Tambutté S; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):5054-8. PubMed ID: 19520577
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against human α- and bacterial/fungal β-carbonic anhydrases.
Rami M; Innocenti A; Montero JL; Scozzafava A; Winum JY; Supuran CT
Bioorg Med Chem Lett; 2011 Sep; 21(18):5210-3. PubMed ID: 21821413
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?
Burghout P; Vullo D; Scozzafava A; Hermans PW; Supuran CT
Bioorg Med Chem; 2011 Jan; 19(1):243-8. PubMed ID: 21163660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
